Sign in

CIK 0001638097 · Non-accelerated filer<br>Smaller reporting company

Entera Bio Ltd.

Sign in to watch
Ticker
ENTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972-2-532-7151
Business address
KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
  1. 3 Insider Initial Statement of Ownership
  2. 4 Grant or award Director acquired 19,117 shares (grant or award)
  3. 4 Grant or award Director acquired 22,815 shares (grant or award)
  4. 4 Grant or award Director acquired 20,790 shares (grant or award)
  5. 4 Grant or award Director acquired 20,034 shares (grant or award)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Director acquired 25,014 shares (grant or award)
  11. 4 Grant or award Chief Executive Officer acquired 420,560 shares (grant or award)
  12. 4 Grant or award Chief Operating Officer acquired 72,993 shares (grant or award)
  13. 4 Grant or award Chief Financial Officer acquired 58,394 shares (grant or award)
  14. 4 Grant or award Chief of R&D acquired 87,591 shares (grant or award)
  15. 4 Open-market buy Director bought 20,000 shares at $1.30 ($26,000)
  16. 4 Open-market buy Director bought 10,000 shares at $1.23 ($12,300)
  17. 4 Open-market buy Director bought 5,000 shares at $1.49 ($7,450)
  18. 4 Open-market buy Director bought 7,500 shares at $1.48 ($11,100)
  19. 4 Open-market buy Director bought 20,000 shares at $1.49 ($29,800)
  20. 4 Open-market buy Director bought 10,000 shares at $1.20 ($12,000)

Page 1 of 7 · 126 filings